Future Pharmacotherapy for Non-alcoholic Steatohepatitis (NASH): Review of Phase 2 and 3 Trials.

Connolly, James J; Ooka, Kohtaro; Lim, Joseph K

Connolly, James J; Ooka, Kohtaro; Lim, Joseph K.

Afiliación

Connolly JJ; Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.
Ooka K; Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Lim JK; Yale Liver Center, Section of Digestive Diseases, Yale University School of Medicine, New Haven, CT, USA.

J Clin Transl Hepatol ; 6(3): 264-275, 2018 Sep 28.

Article en En | MEDLINE | ID: mdl-30271738

Palabras clave

Clinical trials; Fatty liver; Non-alcoholic steatohepatitis; Obeticholic acid; Pharmacotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Clin Transl Hepatol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google